Chief Operating Officer/Co-founder

Stefaan Wera studied biological sciences at the University of Leuven, Belgium (KULeuven) where he also obtained his Ph.D. degree in 1992. After a postdoctoral position at the Laboratoire de Biologie Moléculaire (laboratory for molecular biology) at the University of Liège, Belgium (1992-1993) he was awarded an EMBO-fellowship at the Friedrich-Miescher Institut in Basel, Switzerland (1993-1994). Following an FWO postdoctoral position at the Biochemistry Department at the KULeuven (1994-1996), he worked as Group Leader at the Laboratory for Molecular Cell Biology until the end of 2001. He is co-inventor on a number of patent applications in the domain of drug discovery and author of more than 30 publications in peer-reviewed scientific journals.

Stefaan Wera is a founder and current chief operating officer of ViroVet NV, a biotech company based in Leuven and focused on the development of antiviral drugs and vaccines for livestock. He previously also founded Okapi Sciences, a company that developed antiviral drugs for animals and was acquired by Aratana Therapeutics Inc. Stefaan Wera also founded and was the former CEO of reMYND, a biotech drug discovery & development company based in Leuven. reMYND was founded in 2002 and specialises in the discovery and development of compounds with potential against Alzheimer’s disease.

Other speakers

Emmanuel Hanon CEO Vicebio
Sven Arnouts Business Development Manager Ghent University - Provaxs
Lourdes Mottier Head of Business Development Strategy Elanco Animal Health
Hans Nauwynck - Panelist Professor University of Ghent
Michael Hemprich - Moderator
Joris Vandeputte - Moderator President and Founder VacciM
Lauren Carde - Moderator V.P. Operations and Regulatory Affairs Paul Dick and Associates
Klaus Hellmann - Moderator Chief Veterinary Officer Argenta
Vladimir Pucovsky Scientific Administrator EMA Europa
Jose Carlos Mancera - panelist Senior Clinical Manager Zoetis
Liesbeth Ceelen - Moderator CEO BioLizard
Stein Aerts - panelist Scientific Director & Group Leader VIB
Daniel Jameson - panelist CEO Biorelate
Johannes Charlier Managing Director Kreavet
Jan Wauters Science & Technology Counselor Flanders Investment & Trade
Roxane Feller Secretary General Animal Health Europe
Hans Van Der Weken Postdoctoral Researcher Ghent University
Niels Vander Elst Postdoctoral Researcher Ghent University & KULeuven
Jeroen De Buck Professor Veterinary Microbiology University of Calgary
Kathleen Marchal Professor Bioinformatics University of Ghent
Paul Hodgson Director of Operations VIDO
Nathalie Vanderheijden Coordinator fot the EUP AH&W University of Ghent
Ann Martens Dean of the Faculty of Veterinary Medicine Ghent University
Lionel Malbec Product Manager Quantoom Biosciences
Lucas Decuypere CEO Allegro
Jelena Suran CEO Apiotix Technologies
Paul Dick Founder and President Paul Dick and Associates
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Eduardo Pontes Associate Director Research Alliances (EU) - External Innovation Zoetis
Filip Goossens Senior Investment Manager PMV
Sanjay Vashee Professor and Rockville Campus Director J. Craig Venter Institute
Lucy Davidson Professor of Veterinary Clinical Genetics and MRC Clinician Scientist Fellow Royal Veterinary College
Charles Owen CEO 272BIO
Annelies Bogaerts CDO Benno Therapeutics
Andrea Mariani CEO Soundsafe Care
Thomas Demeester Assistant Professor University of Ghent
Matthias Hofer Managing Partner SC Group (Stonehaven Cozmix Group AG)
Mathieu Peyrou Global Pharmaceuticals Development Director CEVA
Steve Nanchen Head external innovation Elanco

Interested? Register now!

Register here